GW
Therapeutic Areas
Exosla Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EV-based Neurorestorative Therapy | Neurological injury in newborn infants | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| EV-based Neurorestorative Therapy | Neurological injury in newborn infants | Pre-clinical |